Table 3.
Subgroup analysis of the studies to detect the source of heterogeneity for overall satisfaction
| Source | Subcategories | Number of studies | Effect size | Lower CI | Upper CI | Z | I 2 |
|---|---|---|---|---|---|---|---|
| Health service transformation plan | Before | 12 | 0.85 | 0.81 | 0.90 | 37.81 | 96.0% |
| After | 15 | 0.80 | 0.75 | 0.86 | 28.17 | 99.1% | |
| COVID-19 | Before | 21 | 0.84 | 0.80 | 0.88 | 42.70 | 98.7% |
| After | 6 | 0.78 | 0.63 | 0.93 | 10.30 | 98.4% | |
| Location | North | 4 | 0.64 | 0.33 | 0.94 | 4.08 | 99.7% |
| West and north-west | 5 | 0.87 | 0.76 | 0.97 | 16.64 | 97.4% | |
| Tehran and central cities | 12 | 0.86 | 0.82 | 0.90 | 42.49 | 97.9% | |
| Others | 3 | 0.89 | 0.86 | 0.93 | 55.82 | 76.6% | |
| East | 3 | 0.82 | 0.72 | 0.92 | 16.23 | 93.7% | |
| Hospital | Affiliated with the university of medical sciences | 24 | 0.82 | 0.78 | 0.86 | 41.19 | 98.7% |
| Military | 3 | 0.84 | 0.72 | 0.96 | 13.98 | 95.9% | |
| Ward | Different | 15 | 0.80 | 0.74 | 0.85 | 27.51 | 99.1% |
| COVID | 2 | 0.88 | 0.84 | 0.92 | 44.28 | 0.0 | |
| CCU and oncology | 2 | 0.78 | 0.70 | 0.87 | 17.24 | 86.9% | |
| Emergency | 6 | 0.90 | 0.85 | 0.95 | 34.16 | 96.6% | |
| Medical-surgical | 2 | 0.83 | 0.65 | 1.0 | 8.94 | 97.0% | |
| Sample size | Less than 300 patients | 11 | 0.86 | 0.81 | 0.92 | 31.44 | 94.1% |
| More than 300 patients | 16 | 0.80 | 0.75 | 0.85 | 32.11 | 99.1% |